News & Articles

Three therapeutic targets selected across high‑value clinical indications pipeline planned for four radiotherapy assets with in vivo data expected by end of 2026

Programme to focus on advancement of animal-replacement technologies and transition towards human-first, AI-driven drug discovery

This guest editorial explores how emerging AI tools are significantly enhancing the utility of flow cytometry across life sciences and highlights how industry leaders must work together to overcome challenges

Scientists at the University of Edinburgh engineered E. coli bacteria to turn a type of plastic used widely in food and drink packaging – polyethylene terephthalate, or PET – into L-DOPA

Phesi founder, Dr. Gen Li, shares how patient-centric data science and AI are set to transform global healthcare outcomes in cancer

Cast your vote today for the chance to win a $100 Amazon Gift Card

Leadership team is strengthened to support next phase of growth as organization evolves to meet needs of global drug discovery community

Cutting-edge technologies and collaborative research are transforming how scientists overcome genomic instability and accelerate therapeutic protein production

Jiahui International Cancer Center (JICC) stabilized non‑small cell lung cancer (NSCLC) and Parkinson's disease in patient using novel immunotherapy ivonescimab

By adopting Simplicis Ledger™, Flare Therapeutics replaces manual 'human-babysitting' of data with automation-ready infrastructure to scale life sciences R&D

ExPERT DTx streamlines workflows by processing up to 96 samples in a single, three-minute run

Industry leaders outlined how artificial intelligence, digital lab orchestration, and scalable automation will transform scientific discovery and operational resilience in 2026 and beyond

This assay uses hiPSC‑derived cardiomyocytes with Maestro MEA technology to measure electrophysiology across a functional cardiac syncytium

Bioxytran’s drug candidate, PHM23, utilizes a novel mechanism of action that targets galectin proteins critical to viral replication

A breakthrough approach that overcomes scale-up and consistency challenges in microsphere production

In this SelectScience interview, discover why AI in clinical data management must prioritize transparency, traceability, and reproducibility to earn trust in regulated environments

Strategic data collaboration will allow pharmaceutical and biotech companies to connect real-world data with clinical research

TarSeer™ BRETSA™ Target Engagement System enables studies for difficult proteins early in drug discovery

VectorBuilder’s Alan Griffith explains the value of MoA-reflective potency assays for gene therapy development and the benefits of working with assay specialists like Svar Life Science

Tahoe Therapeutics aims to use the speed and accuracy of these automated systems to generate a dataset fifty times larger than its already record-breaking Tahoe 100 million single-cell atlas

A computer simulation technique known as molecular dynamics will be used to study how G-protein-coupled receptors interact with the intracellular effector inside the cell

EpiFinder Analysis Service establishes a new standard for accessible, end-to-end epigenomic analysis, enabling researchers to move confidently from study concept to biological insights

How two CROs are uniting ligand-binding assays and LC-MS expertise to tackle the complexity of modern biologics

Newly patented MICRO‑TAG platform brings real‑time, in‑cell target engagement to the forefront of drug discovery

Equipping labs with a frictionless R&D environment where execution, analytics, and learning are natively connected